Mutations of the AXIN1 gene can be detected in 5–9 %, and mutations of the AXIN2 are reported in ~3% of human HCC or HCC cell lines that carry the wild type CTNNB1 gene [38]. This evidence concerns the gene AXIN2 and hepatocellular carcinoma.